Freshfields and Linklaters advise as competition issues threaten stock exchange merger

Freshfields and Linklaters advise as competition issues threaten stock exchange merger

Börse/LSE tie-up raises regulatory concerns

As Europe’s two largest financial market operators, the London Stock Exchange (LSE) and Deutsche Börse, begin their third attempt at a tie-up, concerns have been raised over antitrust issues.

Continue reading “Freshfields and Linklaters advise as competition issues threaten stock exchange merger”

‘A watershed moment for enforcement’ – Cleary’s Gadhia sizes up class action competition reforms

‘A watershed moment for enforcement’ – Cleary’s Gadhia sizes up class action competition reforms

We have begun a journey into the unknown. The new collective action regime for competition litigation, which came into effect on 1 October, has set the market abuzz with speculation. For example, in the wake of the recent benchmark manipulation scandals, what impact will the new regime have for banks?

Continue reading “‘A watershed moment for enforcement’ – Cleary’s Gadhia sizes up class action competition reforms”

‘A watershed moment for enforcement’ – sizing up class action competition reforms

‘A watershed moment for enforcement’ – sizing up class action competition reforms

Cleary’s Sunil Gadhia and Paul Gilbert on the much-touted reforms of competition disputes

We have begun a journey into the unknown. The new collective action regime for competition litigation, which came into effect on 1 October, has set the market abuzz with speculation. For example, in the wake of the recent benchmark manipulation scandals, what impact will the new regime have for banks?

Continue reading “‘A watershed moment for enforcement’ – sizing up class action competition reforms”

Opting in: Consumer Rights Act ushers in class action model in much touted competition reforms

Opting in: Consumer Rights Act ushers in class action model in much touted competition reforms

The Consumer Rights Act 2015, which comes into force today (1 October), will for the first time establish a procedure for class actions for competition claims, giving consumers and small businesses an easier route to success for claims made over anti-competitive behaviour, including price fixing and market sharing.

Continue reading “Opting in: Consumer Rights Act ushers in class action model in much touted competition reforms”

Landmark European court ruling to open floodgates for EU competition teams

Landmark European court ruling to open floodgates for EU competition teams

In what will inevitably bring more work for competition lawyers acting for Asian clients in Europe, the EU’s highest court has upheld the European Commission’s €288m fine handed to Taiwanese electronics company Innolux in a ruling that puts the reach of EU competition law at odds with other antitrust regulators worldwide.

Continue reading “Landmark European court ruling to open floodgates for EU competition teams”

10 weeks to respond: Cleary Gottlieb called in to handle EU competition claims against Google

10 weeks to respond: Cleary Gottlieb called in to handle EU competition claims against Google

Google’s lawyers at Cleary Gottlieb Steen & Hamilton have been given 10 weeks to respond to the European Commission’s charges that the search engine abused its dominant position to favour its own price comparison service.

Continue reading “10 weeks to respond: Cleary Gottlieb called in to handle EU competition claims against Google”

Guest post: What can IP offer Africa – and what can Africa offer IP?

Guest post: What can IP offer Africa – and what can Africa offer IP?

A handsome book recently arrived on my crowded desk, demanding attention: it’s Innovation & Intellectual Property: Collaborative Dynamics in Africa, edited by scholars Jeremy de Beer, Chris Armstrong, Chidi Oguamanam and Tobia Schonwetter. Published by the UCT Press in association with the IP Unit of the Faculty of Law, University of Cape Town (that’s what ‘UCT’ stands for) and the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ), it’s one of those lovely books that you don’t have to buy since you can read it online or download it in its entirety  all 431 pages of it  by accessing its website here.

Continue reading “Guest post: What can IP offer Africa – and what can Africa offer IP?”

Human nature – cutting edge legal work looms for the drugs revolutionising healthcare

Human nature – cutting edge legal work looms for the drugs revolutionising healthcare

As patents for pioneering biotech drugs near expiry, life sciences companies are hunting new and controversial products. Can law firms help clients win the race?

For those close to the biotech industry, the events of a 2006 clinical trial at Northwick Park Hospital in London are etched firmly in the memory. In what was later dubbed the ‘Elephant Man’ trial, six healthy young men suffered catastrophic multiple organ failures within hours of testing a biologic – a drug created by a biological process – intended to treat leukaemia and rheumatoid arthritis. The volunteers became critically ill, including the loss of fingers and toes, after the monoclonal antibody TGN1412 caused near-fatal side effects. The drug was immediately withdrawn from development and its German-based creator TeGenero filed for insolvency four months later.

Continue reading “Human nature – cutting edge legal work looms for the drugs revolutionising healthcare”